X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Compazine
2. Edisylate Salt, Prochlorperazine
3. Edisylate, Prochlorperazine
4. Maleate, Prochlorperazine
5. Prochlorperazine
6. Prochlorperazine Edisylate Salt
7. Prochlorperazine Maleate
8. Salt, Prochlorperazine Edisylate
1. 1257-78-9
2. Prochlorperazine Edisylate, Usp
3. Prochlorperazine Ethanedisulfonate
4. Pg20w5vqzs
5. Nsc-757299
6. Prochlorperazine Edisylate Salt
7. Prochlorperazine Edisylate [usp]
8. 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine 1,2-ethanedisulfonate (1:1)
9. Compazine Syrup
10. 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;ethane-1,2-disulfonic Acid
11. Phenothiazine, 2-chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-, Ethanedisulfonate
12. Compazine Injection
13. 10h-phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-, 1,2-ethanedisulfonate (1:1)
14. Prochlorperazine Edisylate (usp)
15. Mls001148133
16. Prochlorperazine Ethane Disulfonate
17. Smr000653454
18. Einecs 215-019-1
19. Unii-pg20w5vqzs
20. 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine 1,2-ethanedisulfonate (1:1)
21. Compazine Syrup (tn)
22. Prochlorperazine Edisilate
23. 2-chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine Edisylate
24. Prochlorperazineedisylate,usp
25. Schembl40855
26. Spectrum1500505
27. Chembl1201154
28. Dtxsid4074483
29. Hms501e15
30. Hms1920l08
31. Hms2092c09
32. Hms2234e05
33. Hms3372m12
34. Pharmakon1600-01500505
35. Bcp15822
36. Ccg-39235
37. Mfcd00801002
38. Nsc665801
39. Nsc757299
40. Akos030228220
41. Nsc 757299
42. Nsc-665801
43. Ncgc00094768-01
44. Ncgc00094768-02
45. Ncgc00094768-03
46. Prochlorperazine Ethanedisulphonate
47. 1,2-ethanedisulfonic Acid, Compd. With 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-10h-phenothiazine (1:1)
48. As-60444
49. Ethane-1,2-disulphonic Acid, Compound With 2-chloro-10-(3-(4-methylpiperazin-1-yl)propyl)-10h-phenothiazine (1:1)
50. Prochlorperazine Edisilate [mart.]
51. Prochlorperazine Edisylate [vandf]
52. Prochlorperazine Edisylate [who-dd]
53. D02609
54. Prochlorperazine Edisylate [green Book]
55. Prochlorperazine Edisylate [orange Book]
56. Prochlorperazine Edisylate [usp Monograph]
57. Sr-05000001704
58. Sr-05000001704-1
59. Q27286529
60. Phenothiazine, 2-chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-, Ethanedisulphonate
61. 10h-phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-, 1,2-ethanedisulphonate (1:1)
62. 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine 1,2-ethanedisulphonate (1:1)
63. 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10h-phenothiazine; Ethane-1,2-disulfonic Acid
| Molecular Weight | 564.1 g/mol |
|---|---|
| Molecular Formula | C22H30ClN3O6S3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 563.0985269 g/mol |
| Monoisotopic Mass | 563.0985269 g/mol |
| Topological Polar Surface Area | 161 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 668 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Prochlorperazine edisylate |
| Drug Label | Prochlorperazine edisylate, 2-Chloro-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine 1,2-ethanedisulfonate (1:1), has the following structural formula:C20H24ClN3SC2H6O6S2 MW 564.14Prochlorperazine Edis... |
| Active Ingredient | Prochlorperazine edisylate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 5mg base/ml |
| Market Status | Prescription |
| Company | Bedford; Emcure Pharms; Hikma Maple |
| 2 of 2 | |
|---|---|
| Drug Name | Prochlorperazine edisylate |
| Drug Label | Prochlorperazine edisylate, 2-Chloro-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine 1,2-ethanedisulfonate (1:1), has the following structural formula:C20H24ClN3SC2H6O6S2 MW 564.14Prochlorperazine Edis... |
| Active Ingredient | Prochlorperazine edisylate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 5mg base/ml |
| Market Status | Prescription |
| Company | Bedford; Emcure Pharms; Hikma Maple |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Market Place
